Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response

Journal of Virology

Volumn 73, Issue 12, 1999, Pages 10214-10223

  Lewis, P J ^a,b   Van Drunen Littel Van Den Hurk, S ^a   Babiuk, L A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYTOKINE; DNA VACCINE; GLYCOPROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 4;

ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CYTOKINE RELEASE; HERPES SIMPLEX VIRUS 1; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL;

EID: 0032737033     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.12.10214-10223.1999     Document Type: Article

References (87)

1. Aramaki, Y., H. Suda, and S. Tsuchiya. 1995. Interferon-inductive effect of liposomes as an immunoadjuvant. Vaccine 18:1809-1814.
2. Audibert, F. M., and L. D. Lise. 1993. Adjuvants: current status, clinical perspectives, and future prospects. Immunol. Today 14:281-284.
3. Babiuk, L. A., J. L'Italien, S. van Drunen Littel-van den Hurk, T. Zamb, M. J. P. Lawman, G. Hughes, and G. A. Gifford. 1987. Protection of cattle from bovine herpesvirus type 1 (BHV-1) infection by immunization with individual viral glycoproteins. Virology 159:57-66.
4. Babiuk, L. A., R. C. Wardley, and B. T. Rouse. 1975. Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infect. Immun. 12:958-963.
5. Baca-Estrada, M. E., M. Snider, S. K. Tikoo, R. Harland, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 1996. Immunogenicity of bovine herpesvirus-1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses. Viral Immunol. 9:11-22.
6. Bachman, M. F., T. M. Kundig, H. Hengartner, and R. M. Zinkernagel. 1994. Regulation of IgG antibody titers by the amount persisting of immune-complexed antigen. Eur. J. Immunol. 24:2567-2570.
7. Bachman, M. F., B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 1996. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 183:2259-2269.
8. Bachman, M. F., U. Kalinke, A. Althage, G. Freer, C. Burkhart, H.-P. Roost, M. Aguet, H. Hengartner, and R. M. Zinkernagel. 1997. The role of antibody concentration and avidity in antiviral protection. Science 276:2024-2027.
9. Bos, J. D., and M. L. Kapsenberg. 1993. The skin immune system: progress in cutaneous biology. Immunol. Today 14:75-78.
10. Boyle, C. M., M. Morin, R. G. Webster, and H. L. Robinson. 1996. Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein. J. Virol. 70:9074-9078.
11. Braun, R. P., L. A. Babiuk, and S. van Drunen Little-van den Hurk. 1997. Enhanced immune responses to an intradermally delivered DNA vaccine expressing a secreted form of BHV-1 gD. Vaccine Res. 6:151-164.
12. Bretscher, P. A., G. Wei, J. N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539-542.
13. Brubaker, J. O., C. M. Thompson, L. A. Morrison, D. M. Knipe, G. R. Siber, and R. W. Finberg. 1996. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus. J. Immunol. 157:1598-1604.
14. Cardoso, A. I., M. Blixenkrone-Moller, J. Fayolle, M. Liu, R. Buckland, and T. F. Wild. 1996. Immunization with plasmid DNA encoding for the measles virus haemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. Virology 225:293-299.
15. Coffman, R. L., and T. von der Weid. 1997. Multiple pathways for the initiation of T helper 2 (Th2) responses. J. Exp. Med. 185:373-375.
16. Collins, J. K., A. C. Butcher, and C. A. Riegel. 1985. Immune response to bovine herpesvirus type 1 infections: virus-specific antibodies in sera from infected animals. J. Clin. Microbiol. 21:546-552.
17. Condon, C., S. C. Watkins, C. M. Celluzi, K. Thompson, and L. D. J. Falo. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1122-1128.
18. Corr, M., D. J. Lee, V. Carson, and H. Tighe. 1996. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1555-1560.
19. Coutelier, J.-P., J. T. M. van der Logt, and F. W. A. Heessen. 1991. IgG subclass distribution of primary and secondary immune responses concomitant with viral infection. J. Immunol. 147:1383-1386.
20. Coutelier, J.-P., J. T. M. van der Logt, F. W. A. Heessen, A. Vink, and J. van Snick. 1988. Virally-induced modulation of murine IgG antibody subclasses. J. Exp. Med. 168:2373-2378.
21. Cox, G. J. M., T. J. Zamb, and L. A. Babiuk. 1993. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:5664-5667.
22. Czerkinsky, C., G. Andersson, H. P. Ekre, L. A. Nilsson, L. Klareskog, and O. Ouchterlony. 1988. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 119:29-36.
23. Czerkinsky, C., and J. Holmgren. 1995. The mucosal immune system and prospects for anti-infectious and anti-inflammatory vaccines. Immunologist 3:97-103.
24. Davis, H. L., C. L. Brazolot-Millan, and S. C. Watkins. 1997. Immune-mediated destruction of transfected muscle fibres after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 4:181-188.
25. Donnelly, J. J., J. B. Ulmer, and M. A. Liu. 1994. Immunization with DNA. J. Immunol. Methods 176:145-152.
26. + cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 183:1739-1746.
27. Everson, M. P., D. S. McDuffie, D. G. Lemak, W. J. Koopman, J. R. McGhee, and K. W. Beagley. 1996. Dendritic cells from different tissues induce production of different T cell cytokine profiles. J. Leukoc. Biol. 59:494-498.
28. Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:2278-2284.
29. Fresno, M., M. Kopf, and L. Rivas. 1997. Cytokines and infectious diseases. Immunol. Today 18:56-58.
30. Gause, W. C., M. J. Halvorson, P. Lu, R. Greenwald, P. Linsley, J. F. Urban, and F. D. Finkelman. 1997. The function of co-stimulalory molecules and the development of IL-4-producing T cells. Immunol. Today 18:115-120.
31. Gibbs, E. P. J., and M. M. Rweyemamu. 1977. Bovine herpesviruses, part 1. Vet. Bull. 47:317-343.
32. Guery, J.-C., F. Galbiati, S. Smiroldo, and L. Adorini. 1996. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and 2-microglobulin-deficient BALB/c mice. J. Exp. Med. 183:485-497.
33. Gupta, R. K., E. H. Relyveld, E. B. Lindblad, B. Bizzini, S. Ben-Efraim, and C. K. Gupta. 1993. Adjuvants: a balance between toxicity and adjuvanticity. Vaccine 11:293-306.
34. Hohlfeld, R., and A. G. Engel. 1994. The immunobiology of muscle. Immunol. Today 15:269-274.
35. Hughes, G., L. A. Babiuk, S. van Drunen Littel-van den Hurk. 1988. Functional and topographical analysis of epitopes on bovine herpesvirus type 1 glycoprotein IV. Arch. Virol. 103:47-60.
36. Hutchings, D. L., S. van Drunen Littel-van den Hurk, and L. A. Babiuk. 1990. Lymphocyte proliferative responses to separated bovine herpesvirus 1 proteins in immune cattle. J. Virol. 64:5114-5122.
37. Huygen, K., J. Content, O. Densi, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J.-P. Van Vooren, M. A. Lui, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
38. Inchauspe, G., L. Vitvitski, M. E. Major, G. Jung, U. Spengler, M. Maisonnas, and C. Trepo. 1997. Plasmid DNA expressing a secreted or non-secreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16:185-195.
39. Justewicz, D. M., M. J. Morin, H. L. Robinson, and R. G. Webster. 1995. Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin. J. Virol. 69:7712-7717.
40. Klaus, G. G. B., M. B. Pepys, K. Kitajima, and B. A. Askonas. 1979. Activation of mouse complement by different classes of mouse antibody. Immunology 38:687-695.
41. Kuhn, R. K., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 knockout mice. Science 254:707-710.
42. Li, L., and R. M. Hoffman. 1995. The feasibility of targeted selective gene therapy of the hair follicle. Nat. Med. 1:705-706.
43. Lodmell, D. L., J. J. Esposito, and L. C. Ewalt. 1993. Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro. J. Virol. 67:6080-6086.
44. Mahon, B. P., K. Katrak, A. Nomoto, A. J. Macadam, P. D. Minor, and K. H. G. Mills. 1995. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J. Exp. Med. 181:1285-1292.
45. Mancini, M., M. Hadchouel, H. L. Davis, R. G. Whalen, P. Tiollais, and M.-L. Michel. 1996. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc. Natl. Acad. Sci. USA 93:12496-12501.
46. Manthorpe, M., F. Cornefert-Jemsen, J. Hartikka, J. Felgner, A. Rundell, M. Margalith, and V. Dwarki. 1993. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4:419-431.
47. Michel, M.-L., H. L. Davis, M. Schleef, M. Mancini, P. Tiollais, and R. G. Whalen. 1995. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA 92:5307-5311.
48. Mo, X. Y., S. R. Sarawar, and P. C. Doherty. 1995. Induction of cytokines in mice with parainfluenza pneumonia. J. Virol. 69:1288-1291.
49. Mosmann, T. R., H. Cherwinski, M. B. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
50. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138-146.
51. Nakanaga, K., K. Yamanouchi, and K. Fujiwara. 1986. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J. Virol. 59:168-171.
52. Nguyen, L., D. M. Knipe, and R. W. Finberg. 1994. Mechanism of virus-induced Ig subclass shifts. J. Immunol. 152:478-484.
53. Norman, J. A., P. Hobart, M. Manthorpe, P. Felgner, and C. Wheeler. 1997. Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine 15:801-803.
54. Parish, C. R., and F. Y. Liew. 1971. Immune response to chemically modified flagellin. III. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J. Exp. Med. 135:298-311.
55. Pertmer, T. M., T. R. Roberts, and J. R. Haynes. 1996. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:6119-6125.
56. Peterson, J. D., C. Waltenbaugh, and S. D. Miller. 1992. IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains. Immunology 75:652-658.
57. Pisetsky, D. 1996. Immune activation by bacterial DNA: a new genetic code. Immunity 5:303-310.
58. Pisetsky, D. S. 1997. DNA and the immune system. Ann. Intern. Med. 126:169-171.
59. Pope, M., S. W. Chung, T. Mosmann, J. L. Leibowitz, R. M. Gorczynski, and G. A. Levy. 1996. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2 response, whereas pre-existing antibody partially protects against primary infection. J. Immunol. 156:3342-3349.
60. Raz, E., D. A. Carson, S. E. Parker, T. B. Parr, A. M. Abai, G. Aichinger, S. H. Gromkowski, M. Singh, D. Lew, M. Yankauckas, S. M. Baird, and G. H. Rhodes. 1994. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91:9519-9523.
61. Rhodes, G. H., V. J. Dwarki, A. M. Abai, J. Felgner, P. L. Felgner, S. H. Gromkowski, and S. E. Parker. 1993. Injection of expression vectors containing viral genes induces cellular, humoral, and protective immunity. Vaccines 93. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
62. Schlesinger, J. J., M. W. Brandriss, C. B. Cropp, and T. P. Monath. 1986. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J. Virol. 60:1153-1155.
63. Scott, P. 1993. IL-12 initiation cytokine for cell-mediated immunity. Science 260:496-497.
64. Shearer, G. M., and M. Clerici. 1997. Vaccine strategies: selective elicitation of cellular or humoral immunity? Trends Biotechnol. 15:106-109.
65. Slifka, M. K., and R. Ahmed. 1996. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol. 4:394-400.
66. Snapper, C. M., and J. J. Mond. 1993. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14:15-17.
67. Snapper, C. M., and W. E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947.
68. Spalding, D. M., W. J. Koopman, J. H. Eldridge, J. R. McGhee, and R. M. Stelnman. 1983. Accessory cells in murine Peyer's patches. J. Exp. Med. 157:1646-1659.
69. Stribling, R., E. Brunette, D. Liggitt, K. Gaensler, and R. Debs. 1992. Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. USA 89:11277-11281.
70. Theisen, M., and A. A. Potter. 1992. Cloning, sequencing, expression, and functional studies of a 15,000-molecular-weight Haemophilus somnus antigen similar to Escherichia coli ribosomal protein S9. J. Bacteriol. 174:17-23.
71. Tikoo, S. K., M. Campos, and L. A. Babiuk. 1995. Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv. Virus Res. 45:191-223.
72. Tikoo, S. K., M. Campos, Y. I. Popowych, S. van Drunen Littel-van den Hurk, and L. A. Babiuk. 1995. Lymphocyte proliferative responses to recombinant bovine herpesvirus type 1 (BHV-1) glycoprotein gD (gIV) in immune cattle: identification of a T cell epitope. Viral Immunol. 8:19-25.
73. Tikoo, S. K., D. R. Fitzpatrick, L. A. Babiuk, and T. J. Zamb. 1990. Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J. Virol. 64:5132-5142.
74. Tikoo, S. K., M. D. Parker, J. V. van den Hurk, J. Kowalski, T. J. Zamb, and L. A. Babiuk. 1993. Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV. J. Virol. 67:726-733.
75. Tikoo, S. K., T. J. Zamb, and L. A. Babiuk. 1993. Analysis of bovine herpesvirus 1 glycoprotein gIV truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 67:2103-2109.
76. Ulmer, J. B., R. R. Deck, C. M. Dewitt, J. J. Donnelly, and M. A. Liu. 1996. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89:59-67.
77. Ulmer, J. B., J. J. Donnelly, and M. A. Liu. 1996. DNA vaccines promising: a new approach to inducing protective immunity. ASM News 62:476-479.
78. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. Liu. 1993, Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
79. van Drunen Littel-van den Hurk, S., and L. A. Babiuk. 1986. Polypeptide specificity of the antibody response after primary and recurrent infection with bovine herpesvirus 1. J. Clin. Microbiol. 23:274-282.
80. van Drunen Littel-van den Hurk, S., M. D. Parker, B. Massie, J. V. van den Hurk, R. Harland, L. A. Babiuk, and T. Zamb. 1993. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11:25-35.
81. van Drunen Littel-van den Hurk, S., R. Braun, P. J. Lewis, B. C. Karvonen, M. Baca-Estrada, D. McCartney, T. Watts, and L. A. Babiuk. 1998. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 79:831-839.
82. van Drunen Littel-van den Hurk, S., S. K. Tikoo, X. Liang, and L. A. Babiuk. 1993. Bovine herpesvirus-1 vaccines. Immunol. Cell Biol. 71:405-420.
83. van Drunen Littel-van den Hurk, S., R. P. Braun, B. C. Karvonen, T. King, D. Yoo, and L. A. Babiuk. 1999. Immune responses and protection induced by DNA vaccines encoding bovine parainfluenzavirus type 3 (BPIV-3) glycoproteins. Virology 260:35-46.
84. Wheeler, C. J., P. L. Felgner, Y. J. Tsai, J. Marshall, L. Sukhu, S. G. Doh, J. Hartikka, J. Nietupski, M. Manthorpe, M. Nichols, M. Plewe, X. Liang, J. Norman, and S. H. Cheng. 1996. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl. Acad. Sci. USA 93:11454-11459.
85. Wyler, R., M. Engels, and M. Schwyzer. 1989. Infectious bovine rhinotracheitis/vulvovaginitis (BHV-1). In G. Wittmann (ed.), Herpesvirus diseases of cattle, horses and pigs. Developments in veterinary virology, p. 1-172. Kluwer Academic Publishers, Boston, Mass.
86. Yang, X., R. Gieni, T. R. Mosmann, and K. T. Hayglass. 1993. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J. Exp. Med. 178:349-353.
87. Yates, W. D. G. 1982. A review of infectious rhinotracheitis, shipping-fever pneumonia, and viral-bacterial synergism in respiratory diseases of cattle. Can. J. Comp. Med. 40:225-263.